Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma
Decysin-1 (ADAMDEC1) is an orphan ADAM-like metalloprotease with unknown biological function and a short domain structure. ADAMDEC1 mRNA has previously been demonstrated primarily in macrophages and mature dendritic cells. Here, we generated monoclonal antibodies (mAbs) against the mature ADAMDEC1 p...
Päätekijät: | Lund, J, Elimar Bitsch, A, Grønbech Rasch, M, Enoksson, M, Troeberg, L, Nagase, H, Loftager, M, Overgaard, M, Petersen, H |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Taylor and Francis
2017
|
Samankaltaisia teoksia
-
Evidence for Restricted Reactivity of ADAMDEC1 with Protein Substrates and Endogenous Inhibitors.
Tekijä: Lund, J, et al.
Julkaistu: (2015) -
ADAMDEC1 accelerates GBM progression via activation of the MMP2-related pathway
Tekijä: Huimin Qi, et al.
Julkaistu: (2022-09-01) -
ADAMDEC1 promotes the malignant progression of cholangiocarcinoma by regulating NF-κB signaling pathway
Tekijä: Shuo Zhou, et al.
Julkaistu: (2025-01-01) -
ADAMDEC1 and FGF2/FGFR1 signaling constitute a positive feedback loop to maintain GBM cancer stem cells
Tekijä: Ana Jimenez-Pascual, et al.
Julkaistu: (2020-01-01) -
Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains
Tekijä: Julio Plaza-Díaz, et al.
Julkaistu: (2017-05-01)